TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
陳泱伊Chen, Yang-Yi
- Principal Investigator
- Clinical Trial Experience (year) 7 years 9 個月
-
1050556@kmuh.org.tw
Publication
3Publications
1
Chen, Yang-Yi, Wei-An Chang, En-Shyh Lin, Yi-Jen Chen, and Po-Lin Kuo.
Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets. Diagnostics 2019, 9, 59. https://doi.org/10.3390/diagnostics9020059
Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets. Diagnostics 2019, 9, 59. https://doi.org/10.3390/diagnostics9020059
2
Chen, Yang-Yi et al. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen. Eur J Dermatol. 2019 Dec 1;29(6):667-669. doi: 10.1684/ejd.2019.3668.
3
Lin ES, Chang WA, Chen YY, Wu LY, Chen YJ, Kuo PL. Deduction of novel genes potentially involved in keratinocytes of type 2 diabetes using next-generation sequencing and bioinformatics approaches. Journal of clinical medicine vol. 8,1 73. 10 Jan. 2019, doi:10.3390/jcm8010073
